Annual Report

Vaxcyte, Inc. Filed 2024-02-27 Acc 0000950170-24-021145

Documents 1

2025-02-25 10-K Annual Report
2024-02-27 4 CHIEF EXECUTIVE OFFICER sold 45,000 shares at an average $78.09 ($3,514,106)
2024-02-27 S-8 Securities Offered to Employees in Benefit Plans
2024-02-27 10-K Annual Report
2024-02-27 8-K Results of operations
2024-02-26 144 Sale of Securities
2023-02-27 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading pcvx-20231231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…